ViraTherapeutics
AustriaEntry
2013
Hold
5yr
Exit
2018
Who owns ViraTherapeutics?
ViraTherapeutics is an Austrian Biotech company, now owned by Boehringer Ingelheim, which acquired it in 2018 from Boehringer Ingelheim Venture Fund.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
Boehringer Ingelheim
Exit Year
2018
More from Boehringer Ingelheim Venture Fund
Other portfolio companies in the same fund.
Germany
US
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns ViraTherapeutics?
ViraTherapeutics is now owned by Boehringer Ingelheim, which acquired it in 2018 from Boehringer Ingelheim Venture Fund.
When did Boehringer Ingelheim acquire ViraTherapeutics?
Boehringer Ingelheim acquired ViraTherapeutics in 2018, buying from Boehringer Ingelheim Venture Fund.
Who did ViraTherapeutics sell to?
Boehringer Ingelheim Venture Fund sold ViraTherapeutics to Boehringer Ingelheim in 2018 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue